[144] Coherent Corp. SEC Filing

Rhea-AI Filing Summary

Coherent Corp. (COHR) Form 144 notice: An insider proposes to sell 291 restricted stock units of common stock, with an aggregate market value of $26,670.15, through Morgan Stanley Smith Barney on the NYSE, with an approximate sale date of 08/15/2025. The securities were acquired as Restricted Stock Units on 01/31/2024 from the issuer and were paid for on that date.

The filing also discloses recent Rule 10b5-1 sales by the same person: 3,100 shares on 07/17/2025 for $310,000.00 and 5,458 shares on 07/16/2025 for $526,435.56. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and references reliance on a 10b5-1 trading plan where applicable.

Positive

• Disclosure compliance: Form 144 properly discloses proposed sale details including broker, quantity, value, and acquisition method
• Use of 10b5-1 plan: Recent sales were executed under Rule 10b5-1, indicating pre-arranged trading and potential reduction of insider trading concerns

Negative

• Insider selling activity: Recent 10b5-1 sales of 8,558 shares for $836,435.56 represent insider disposition that some investors may view negatively
• Limited context: The filing does not provide information on the insider's remaining holdings or how these sales relate to ownership percentage

Insights

Securities Analyst

TL;DR: Insider plans a small sale of 291 RSUs and recently completed larger 10b5-1 sales; disclosure indicates trading under an established plan.

The proposed sale of 291 RSUs valued at $26,670.15 is modest in size relative to typical market-cap considerations and appears to be executed through a broker under normal procedures. Recent 10b5-1 executions on 07/16/2025 and 07/17/2025 totaling 8,558 shares and gross proceeds of $836,435.56 show active disposition under a pre-arranged plan. From a disclosure and compliance perspective the filing meets Rule 144 requirements and includes the required representation about material nonpublic information.

Corporate Governance Expert

TL;DR: The filing documents routine insider sales and adherence to Rule 10b5-1; no governance red flags in the notice itself.

The Form 144 identifies the nature of acquisition (RSUs) and provides broker, quantity, and value details for the proposed sale, along with recent 10b5-1 sales. The inclusion of the seller's attestation about lack of undisclosed material adverse information and the stated plan adoption/instruction date (where applicable) aligns with best-practice disclosure. The filing does not present governance issues by itself but is a data point investors may consider alongside operational results.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	291	26670.15	155805474	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2024	Restricted Stock Units	Issuer			291	01/31/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER KOEPPEN 375 Saxonburg Blvd. Saxonburg PA 16056	Common	07/17/2025	3100	310000.00
10b5-1 Sales for CHRISTOPHER KOEPPEN 375 Saxonburg Blvd. Saxonburg PA 16056	Common	07/16/2025	5458	526435.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the COHR Form 144 disclose about the proposed sale?

It discloses a proposed sale of 291 common stock RSUs with an aggregate market value of $26,670.15 scheduled approximately for 08/15/2025 through Morgan Stanley Smith Barney on the NYSE.

Were there recent insider sales by the same person for COHR?

Yes. The filing lists Rule 10b5-1 sales of 3,100 shares on 07/17/2025 for $310,000.00 and 5,458 shares on 07/16/2025 for $526,435.56.

How were the securities acquired that are being proposed for sale?

The securities were acquired as Restricted Stock Units on 01/31/2024 from the issuer, with an amount of 291 units shown.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. By signing the notice, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.